Long-term safety and secondary efficacy endpoints in the ENGOT-OV16/NOVA phase III trial of niraparib in recurrent ovarian cancer
- Resource Type
- Abstract
- Authors
- Matulonis, Ursula; Herrstedt, Jørn; Oza, Amit; Mahner, Sven; Redondo, Andrés; Berton, Dominique; Berek, Jonathan; Lund, Bente; Marmé, Frederik; González-Martín, Antonio; Tinker, Anna; Ledermann, Jonathan; Benigno, Benedict; Lindahl, Gabriel; Colombo, Nicoletta; Li, Yong; Gupta, Divya; Monk, Bradley; Mirza, Mansoor
- Source
- In Gynecologic Oncology August 2021 162 Supplement 1:S24-S25
- Subject
- Language
- ISSN
- 0090-8258